PACB Jan 2025 5.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 11:43AM EDT. Market open.
| Previous Close | 0.1100 |
| Open | 0.1000 |
| Bid | 0.0500 |
| Ask | 0.1000 |
| Strike | 5.00 |
| Expire Date | 2025-01-17 |
| Day's Range | 0.1000 - 0.1000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 3k |
ZacksPacific Biosciences (PACB) Upgraded to Buy: Here's What You Should Know
Pacific Biosciences (PACB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Simply Wall St.Pacific Biosciences of California, Inc. (NASDAQ:PACB) Analysts Just Slashed This Year's Revenue Estimates By 18%
Market forces rained on the parade of Pacific Biosciences of California, Inc. ( NASDAQ:PACB ) shareholders today, when...
ZacksPacBio (PACB) Preliminary Q1 Revenues Dampened by Purchase Delays
PacBio's (PACB) revenue growth in the first quarter is likely to have been hampered by an increasing number of customers delaying instrument purchases and softness in consumable shipments.
© 2024 Yahoo. All rights reserved.